Pioneering Pain-free Solutions
We leverage the power of technology to develop transformative, accurate solutions that improve quality of life.
We're on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.
Our Technology
Revolutionizing Portable Testing Through Fingertip Sweat Analysis
Our cutting-edge intelligent drug screening system detects commonly abused drugs via the fingertips. The system’s ease of use and portability make it a convenient solution for reliable drug screening and potential misuse within the 16 hours before testing.
INTELLIGENT DRUG SCREENING
A Dignified Approach to Testing
Our Intelligent Drug Screening system tests fingertip sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine. Samples are collected in less than one minute and results displayed in less than ten minutes.
![Efficient Drug Screening](https://ibs.inc/wp-content/uploads/2023/04/efficient-drug-screening.jpg)
![The Saliva Glucose Biosensor Hand](https://ibs.inc/wp-content/uploads/2023/04/biosensor-hand-1024x912.png)
THE BIOSENSOR PLATFORM
A Platform for Multiple Diagnostic Tests
The biosensor platform is a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.
News Updates
![INBS Announces Qabas as Exclusive Distributor in Saudi Arabia](https://ibs.inc/wp-content/uploads/2024/07/INBS-Announces-Qabas-as-Exclusive-Distributor-in-Saudi-Arabia-300x188.png)
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
New York, July 24, 2024 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced QabasTech (“Qabas”)
![INBS Advances FDA 510(k) Pathway with Biocompatibility Study](https://ibs.inc/wp-content/uploads/2024/07/INBS-Advances-FDA-510k-Pathway-with-Biocompatibility-Study-300x188.png)
Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success
NEW YORK, 18 July, 2024 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful
![INBS Strengthens UK Market Position with Addition of Key Manufacturing Accounts](https://ibs.inc/wp-content/uploads/2024/07/INBS-Strengthens-UK-Market-Position-with-ADDITION-OF-KEY-MANUFACTURING-ACCOUNTS-300x188.png)
Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Account
New York, July 9, 2024 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition